Product Description
Clobetasone is a medicince used on the skin to treat swelling, itching and irritation. Clobetasone comes as cream or ointment. You can buy it from pharmacies or supermarkets.
Mechanisms of Action: GR Agonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Topical
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Australia | Austria | Bangladesh | Belgium | Brazil | Canada | Chile | China | Colombia | Dominican Republic | Egypt | Finland | Hong Kong | India | Ireland | Italy | Korea | Malaysia | Malta | Morocco | Netherlands | New Zealand | Pakistan | Peru | Portugal | Saudi Arabia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Turkey | United Kingdom | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: GlaxoSmithKline
Company Location: BRENTFORD MIDDLESEX X0 TW8 9GS
Company CEO: Emma Walmsley
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count: 1
Highest Development Phases
Phase 3: Dermatitis, Atopic
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
2015-004899-30 | P3 |
Active, not recruiting |
Dermatitis, Atopic |
2016-12-27 |